首页> 外文OA文献 >Fenugreek Seed Extract Inhibit Fat Accumulation and Ameliorates Dyslipidemia in High Fat Diet-Induced Obese Rats
【2h】

Fenugreek Seed Extract Inhibit Fat Accumulation and Ameliorates Dyslipidemia in High Fat Diet-Induced Obese Rats

机译:胡芦巴籽提取物抑制脂肪积累和改善高脂饮食诱导的肥胖大鼠的血脂血症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigated the inhibitory effect of aqueous extract of Trigonella foenum-graecum seeds (AqE-TFG) on fat accumulation and dyslipidemia in high fat diet- (HFD-) induced obese rats. Female Wistar rats were fed with HFD ad libitum, and the rats on HFD were treated orally with AqE-TFG or orlistat ((HFD for 28 days + AqE-TFG (0.5 and 1.0 g/kg) or orlistat (10 mg/kg) from day 8 to 28), respectively. Treatment with AqE-TFG produced significant reduction in body weight gain, body mass index (BMI), white adipose tissue (WAT) weights, blood glucose, serum insulin, lipids, leptin, lipase, and apolipoprotein-B levels and elevation in adiponectin levels. AqE-TFG improved serum aspartate amino transferase (AST), alanine amino transferase (ALT), and lactate dehydrogenase (LDH) levels. AqE-TFG treatment reduced the hepatic and cardiac thiobarbituric acid reactive substances (TBARS) and elevated the antioxidant enzyme (glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT)) levels. In addition, liver and uterine WAT lipogenic enzyme (fatty acid synthetase (FAS) and glucose-6-phosphate dehydrogenase (G6PD)) activities were restored towards normal levels. These findings demonstrated the preventive effect of AqE-TFG on fat accumulation and dyslipidemia, due to inhibition of impaired lipid digestion and absorption, in addition to improvement in glucose and lipid metabolism, enhancement of insulin sensitivity, increased antioxidant defense, and downregulation of lipogenic enzymes.
机译:本研究调查了三核菌 - GRAECUM种子(AQE-TFG)水提取物对高脂饮食(HFD-)诱导的肥胖大鼠脂肪积累和血脂血症的抑制作用。用HFD AD Libitum喂养雌性Wistar大鼠,用Aqe-TFG或Orlistat口服HFD的大鼠((HFD为28天+ AQE-TFG(0.5和1.0g / kg)或orlistat(10mg / kg)分别从第8至28天)。用AQE-TFG治疗产生体重增加,体重指数(BMI),白色脂肪组织(WAT)重量,血糖,血清胰岛素,脂质,瘦素,脂肪酶和脂蛋白-B水平和脂肪蛋白水平的升高。AQE-TFG改进血清天冬氨酸氨基转移酶(AST),丙氨酸氨基转移酶(ALT)和乳酸脱氢酶(LDH)水平。AQE-TFG治疗降低了肝和心脏硫尿酸反应性物质(TBARS)并升高抗氧化酶(谷胱甘肽(GSH),超氧化物歧化酶(SOD)和过氧化氢酶(猫))水平。此外,肝脏和子宫WAT脂肪生成酶(脂肪酸合成酶(FAS)和葡萄糖-6-磷酸盐脱氢酶(G6PD))活性恢复正常水平。这些发现由于抑制脂质消化和吸收的抑制,证明了AQE-TFG对脂肪积聚和血脂血症的预防效果,除了改善葡萄糖和脂质代谢,提高胰岛素敏感性,增加抗氧化剂防御和脂质酶的下调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号